Evidence map›Paper›PMID 22820803›Full record

ArticleJournal of acquired immune deficiency syndromes (1999)2012

Outcomes following virological failure and predictors of switching to second-line antiretroviral therapy in a South African treatment program.

Victoria Johnston, Katherine L Fielding, Salome Charalambous, Gavin Churchyard, Andrew Phillips, Alison D Grant

Abstract read
In one paragraph

Article in Journal of acquired immune deficiency syndromes (1999), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Victoria JohnstonLondon School of Hygiene and Tropical Medicine, Keppel Street, London, United Kingdom. victoria.johnston@lshtm.ac.uk
Katherine L Fielding
Salome Charalambous
Gavin Churchyard
Andrew Phillips
Alison D Grant

Funding

STRENGTHENING WORKPLACE INTERVENTIONS IN SMME'S IN SOUTH AFRICAU2GPS000811 · PS · AURUM INSTITUTE NPC · PI CLARK, DAVE · 2007 to 2011
$75.0M
NCHHSTP CDC HHS U2G PS000811PEPFAR 5U2GPS000811Wellcome Trust 087261Wellcome Trust 087261/Z/08/Z
6 · The paper itself

Abstract

objectivesWithout resistance tests, deciding which patients with virological failure should switch to second-line antiretroviral therapy (ART) is difficult. The factors influencing this decision are poorly understood. We assess predictors of switching regimens after virological failure.

designRetrospective cohort study using clinical data from a South African ART program with 6-monthly viral load (VL) monitoring.

methodsWe constructed a dataset of patient visits occurring following first-line virological failure, and used random effects logistic regression (accounting for individual-level and clinic-level clustering) to assess predictors of switching at each visit.

resultsOne thousand six hundred sixty-eight patients with virological failure (73% male, mean age 41 years, median CD4 184 cells/mm, mean log10 VL 4.3) contributed 1922 person-years of viremia. 12 months after failure, the cumulative incidence of switching regimen, viral resuppression, or death was 16.9%, 13.2%, and 4.6%, respectively. In adjusted analysis, switching was more likely at the third or subsequent visit after failure; in visits occurring in 2008 versus 2003 to 2007; and in patients with ART experience pre-programme, current high VL or low CD4 count. Switching was less likely in patients with no clinic contact for 4 months, or declining VL. Switching rates varied between clinics with clinic-level clustering evident in the final model (P <0.001).

conclusionsDespite 6-monthly virological monitoring and recommendations to switch after adherence interventions and confirmed viremia, patients experienced delayed switching. Individual-level covariates influenced switching but did not account for variable switching rates between clinics, suggesting differences in guideline implementation. In certain circumstances delays may be warranted; however understanding barriers to guideline implementation will limit unnecessary delays.

Indexed as

AdultAnti-HIV AgentsAntiretroviral Therapy, Highly ActiveDrug Resistance, ViralFemaleHIV InfectionsHumansLogistic ModelsMaleRetrospective StudiesSouth AfricaTreatment FailureTreatment OutcomeViral LoadAnti-HIV Agents

Identifiers

PMID22820803
PMCPMC3840925

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.